Overview
FOCL market data
Price History
FOCL price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.78 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.42 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -44.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $4.18 – $6.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $178M · P/S 2.55.
Company News
8-K filing — EDAP TMS SA (FOCL)SEC EDGAR · Aug 14, 2026, 10:00 AM
Edap TMS Q2 2026 Earnings Call: Complete TranscriptBenzinga · Aug 13, 2026, 9:29 PM
FocalTherics Q2 EPS $(0.38) Misses $(0.20) Estimate, Sales $13.200M Miss $14.440M EstimateBenzinga · Aug 13, 2026, 8:03 PM
FocalTherics shares are trading lower after the company announced the pricing of its $40 million offering of 8.425 million ADSs at $4.75 per ADS.Benzinga · Aug 12, 2026, 12:49 PM
Reported Earlier, FocalTherics Prices Underwritten Offering Of 8,425,000 ADSs At $4.75 Per ADS For $40.0M Gross ProceedsBenzinga · Aug 12, 2026, 7:19 AM
12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · Aug 11, 2026, 9:06 PM
FocalTherics Reports Preliminary Q2 Sales Of $12.7M-$13.2M, Up 34%-39% Year-On-YearBenzinga · Aug 11, 2026, 8:34 PM
FocalTherics Announces Underwritten Public Offering Of ADSsBenzinga · Aug 11, 2026, 8:24 PM
FocalTherics Launches First European Commercial Endometriosis Focal One Program With Treatment Of Initial Patients In Toulouse, FranceBenzinga · Jun 30, 2026, 11:40 AM
FocalTherics Expanding Focal One Robotic HIFU Access Under Signed Agreement With MellingMedical To Federal Healthcare ProvidersBenzinga · Jun 16, 2026, 11:40 AM